1/10/2012

Marina Biotech Provides Update on its Broad Nucleic Acid-Based Drug Discovery Platform and 2012 Goals

1/19/2012 

Marina Biotech Receives Notice of Acceptance for Patent Broadly Covering Its Unlocked Nucleobase Analog (UNA) Technology

2/22/2012 

Marina Biotech Receives Notice of Allowance for U.S. Patent Related to Its Lipid Based Nucleic Acid Drug Delivery Platform

2/29/2012

Marina Biotech Presents Advances in Oral Delivery of Nucleic Acids at AsiaTIDES Conference in Tokyo

3/14/2012

Marina Biotech and ProNAi Therapeutics Announce License Agreement for the Development of DNAi-based Therapeutics

Scroll Up